StockDuty ← Dashboard Nov 03, 2026 11:08 PM ET
SignalCorporate

$KMB (KIMBERLY CLARK) — 8-K: Kimberly-Clark completes Kenvue acquisition, reiterates $2.1 billion run-rate synergies

KMB
$109.43
+2.09%
Kimberly-Clark closed its acquisition of Kenvue, creating a combined portfolio that includes 10 billion-dollar brands such as Huggies, Listerine, Neutrogena, Tylenol and Johnson's Baby. The company reiterated anticipated run-rate synergies of $2.1 billion, with a value capture plan and pipeline already charted. Global spending on health and wellness exceeds $500 billion annually, which Kimberly-Clark cited as demand it is positioned to capture across baby care, women's health and active aging.
Kimberly-Clark closed its acquisition of Kenvue, creating a combined portfolio that includes 10 billion-dollar brands such as Huggies, Listerine, Neutrogena, Tylenol and Johnson's Baby. The company re
Sources